Pharma point alzheimer's disease   india drug forecast and market analysis to 2022
Upcoming SlideShare
Loading in...5
×
 

Pharma point alzheimer's disease india drug forecast and market analysis to 2022

on

  • 107 views

“PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the ...

“PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease. To Know More :

Statistics

Views

Total Views
107
Views on SlideShare
107
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharma point alzheimer's disease   india drug forecast and market analysis to 2022 Pharma point alzheimer's disease india drug forecast and market analysis to 2022 Presentation Transcript

  • PharmaPoint: Alzheimer's Disease India Drug Forecast and Market Analysis to 2022 Bharat Book Bureau One-Stop Shop for Business Information www.bharatbook.com
  • Summary “PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease. The Indian pharmaceutical market consists primarily of domestically manufactured generics and is therefore not affected by erosion of the sales of patented drugs when these products enter the market. By integrating only generics into the market, medicines can be easily distributed to the large population being served without restricting access by requiring a co-payment from private insurance companies. This model of healthcare does not attract newly-developed agents, but rather those that are cost-effective. P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • Scope • Overview of epidemiology, etiology, Alzheimer’s Disease, including symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for the top drugs in India from 2012-2022. • Analysis of the impact of key events as well the drivers and restraints affecting India Alzheimer’s Disease market. P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • Reasons To Buy • Understand and capitalize by identifying products that are most likely to ensure a robust return • Stay ahead of the competition by understanding the changing competitive landscape for Alzheimer’s Disease • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential • Make more informed business decisions from insightful and in-depth analysis of drug performance • Obtain sales forecast for drugs from 2012-2022 in India P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • Table of Contents 1. Table of Contents 2. Introduction 3. Disease Overview 4. Disease Management 5. Competitive Assessment 6. Opportunity and Unmet Need 7. Pipeline Assessment 8. Market Outlook 9. Appendix P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • Related Reports  Market Access for Orphan Drugs: assessing the global landscape  Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis  2014 Analysis of the Global Drugs of Abuse Testing Market  2014 Analysis of the US Drugs of Abuse Point-of-Care Testing Market  Global Markets and Manufacturing Technologies for Protein Drugs Focus on Blood Factors, Vaccines and Peptide Antibiotics P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • Custom Research Incase the reports don’t match your requirement then we can do a Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us at a unique position to take up Custom Research demands of yours. We provide the specifications of the custom research job to a dedicated team comprising of researchers, analysts and industry experts, who have close experience and understanding of global markets, competitive landscapes, various business models, market shares, drivers, restraints and benchmarks. http://www.bharatbook.com/customResearch.asp P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com
  • For More Information You Can Visit: http://www.bharatbook.com/healthcare-market-researchreports/pharmapoint-alzheimers-disease-india-drug-forecast-andmarket-analysis-to-2022.html Request Sample Pages Contact Us:Call India: +91-22-27810772/73 Call USA/Canada (Toll Free): 1-866-279-8368 For Live Chat - http://bit.ly/19m3TU4 Follow/Like Us on:- P: +91-22-27810772/73| E: info@bharatbook.com| www.bharatbook.com